dev.PILOTforPulmonary.orgdev.PILOTforPulmonary.orgdev.PILOTforPulmonary.org

 x 

0 Activities
0 Activities
  • No Saved Activities
  • Home
  • Education
    • Top Disease Areas
      • Asthma
      • Bronchiectasis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • COVID-19
      • Idiopathic Pulmonary Fibrosis
      • Interstitial Lung Disease (ILD)
      • Nontuberculous Mycobacteria (NTM)
      • Non-Small Cell Lung Cancer (NSCLC)
      • Pulmonary Hypertension (PH/PAH)
      • Radiology
      • Rheumatoid Conditions
    • Content Type
      • Animation
      • EXPLORE™
      • Interactive Cases
      • Podcast
      • Slides
      • Video
      • Webinar

    Search Education

    Latest Education

    9460-repi3

    Race, Ethnicity & Pulmonary Function Test Interpretation

    9465_263x1494

    Slides: Bronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers

    9465_263x149

    Bronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers

    Menu Ad
  • Register
  • Contact Us
  • Login

    Login

    Create an account
    • Forgot your password?

Education

  1. Home
  2. Education
  3. Top Disease Areas
  4. Radiology
  5. Specialty Area

 

Jointly Accredited Provider

Search

  • Credit Type
    • CME (AMA PRA Category 1 Credit)
    • MOC (Maintenance of Certification)
  • Disease Area
    • Alpha-1 Antitrypsin Deficiency (AATD)
    • Asthma
    • Bronchiectasis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • COVID-19
    • Cystic Fibrosis (CF)
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Interstitial Lung Disease (ILD)
    • Non-Small Cell Lung Cancer (NSCLC)
    • Nontuberculous Mycobacteria (NTM)
    • Pulmonary Hypertension (PH/PAH)
    • Radiology
    • Rheumatoid Conditions
  • Content Type
    • Animation
    • EXPLORE™
    • Interactive Cases
    • Podcast
    • Slides
    • Video
    • Webinar

Beyond Pulmonary

Browse over 450 CME/CE courses on FranceFoundation.com

VIEW ALL EDUCATION
  • Start
  • «
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • »
  • End
Page 29 of 44
Results 421 - 435 of 652
No image set
Clinical Pearls from New Orleans 2019
No image set
Inhaled NO in Patients at Risk for Pulmonary Hypertension
No image set
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
No image set
Considerations for Geriatric ILD Patients
No image set
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
No image set
Emerging Diagnostic Approaches to Patients with ILD
No image set
Goals of Care Across the Disease Continuum in IPF
No image set
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
No image set
Current Perspective on Antifibrotic Therapy for Patients with IPF
castro-tff
Updates in SMA from Austin, Texas
No image set
Technology Improving SMA Patients’ Quality of Life
No image set
Nusinersen Treatment Outcomes in Later-Onset SMA
No image set
Patients with Severe SMA Need Additional Respiratory Management
Castro_02
Clear Expectations Needed in SMA Patient Management
Castro_01
Improvements in Quality of Life for Patients with Neuromuscular Diseases
  • Start
  • «
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • »
  • End
Page 29 of 44

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA

Copyright © 2024 The France Foundation All Rights Reserved.
The France Foundation | Privacy Policy | Terms of Use

Search

  • Home
  • Education
    • Top Disease Areas
      • Asthma
      • Bronchiectasis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • COVID-19
      • Idiopathic Pulmonary Fibrosis
      • Interstitial Lung Disease (ILD)
      • Nontuberculous Mycobacteria (NTM)
      • Non-Small Cell Lung Cancer (NSCLC)
      • Pulmonary Hypertension (PH/PAH)
      • Radiology
      • Rheumatoid Conditions
    • Content Type
      • Animation
      • EXPLORE™
      • Interactive Cases
      • Podcast
      • Slides
      • Video
      • Webinar
  • Register
  • Contact Us
  • Login
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.
I accept